Does lapatinib, a small-molecule tyrosine kinase inhibitor, constitute a breakthrough in the treatment of breast cancer?
Keyword(s):
2013 ◽
Vol 13
(6)
◽
pp. 686-697
◽
Keyword(s):
Keyword(s):
Keyword(s):
2000 ◽
Vol 48
(5)
◽
pp. 1519-1528
◽
2018 ◽
Vol 144
(3)
◽
pp. 651-664
◽
2018 ◽
Vol 59
(9)
◽
pp. 1386-1391
◽
Keyword(s):
2019 ◽
Vol 38
(1)
◽
2019 ◽
Vol 235
(2)
◽
pp. 1259-1273
◽
Keyword(s):
Keyword(s):